Mydriacyl

Cycloplegia, Induced Hyperthermia, diagnostic procedures + 6 more

Treatment

17 Active Studies for Mydriacyl

What is Mydriacyl

Tropicamide

The Generic name of this drug

Treatment Summary

Tropicamide is a type of medication that blocks the action of the chemical acetylcholine, which helps to relax the muscles in the eyes. It is used to dilate the pupils and paralyze the ciliary muscle during eye exams and ocular procedures. It is also used in combination with another drug, hydroxyamphetamine, for the same purpose. Tropicamide has also been studied as a potential treatment for drooling in people with Parkinson's disease when taken orally.

Mydriacyl

is the brand name

Mydriacyl Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Mydriacyl

Tropicamide

1959

16

Effectiveness

How Mydriacyl Affects Patients

Tropicamide is a drug used to widen the pupils and temporarily paralyze the muscles in the eye. It usually starts to work within 10-15 minutes, and can last up to 24 hours. It can also increase the pressure in the eye, but serious side effects are not normally seen. It has been used in Parkinson's Disease to reduce saliva production, and has also been shown to reduce tremors in rodent models.

How Mydriacyl works in the body

Tropicamide is a drug that blocks the activity of muscarinic receptors, which are found in the eye and salivary glands. In the eyes, these receptors play a role in pupil constriction and near vision. By blocking these receptors, tropicamide causes the pupil to dilate and prevents near vision. It also blocks muscarinic receptors found in salivary glands, which helps reduce excessive saliva production.

When to interrupt dosage

The dosage of Mydriacyl is contingent upon the recognized affliction, comprising diagnostic tests, induction of Cycloplegia and Cycloplegia. The amount is additionally dependent on the mode of delivery (e.g. Solution or Solution - Ophthalmic) specified in the table below.

Condition

Dosage

Administration

diagnostic procedures

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

induction of partial cycloplegia

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

Epilepsies, Partial

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

Induced Hyperthermia

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

induction of Cycloplegia

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

Ocular Anesthesia

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

Pupil

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

Cycloplegia

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

Cataract Surgery

, 10.0 mg/mL, 5.0 mg/mL, 2.5 mg/mL, 0.8 %, 1.0 %, 0.5 %

Solution / drops, Solution / drops - Ophthalmic, Ophthalmic, , Solution, Solution - Ophthalmic, Liquid, Liquid - Ophthalmic

Warnings

Mydriacyl has one recognized contraindication, so it should not be employed for the situations listed in the subsequent table.

Mydriacyl Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Tropicamide may interact with Pulse Frequency

There are 20 known major drug interactions with Mydriacyl.

Common Mydriacyl Drug Interactions

Drug Name

Risk Level

Description

Aclidinium

Minor

The risk or severity of adverse effects can be increased when Tropicamide is combined with Aclidinium.

Agmatine

Minor

The risk or severity of adverse effects can be increased when Tropicamide is combined with Agmatine.

Alcuronium

Minor

The risk or severity of adverse effects can be increased when Tropicamide is combined with Alcuronium.

Alloin

Minor

The therapeutic efficacy of Alloin can be decreased when used in combination with Tropicamide.

Amantadine

Minor

The risk or severity of adverse effects can be increased when Tropicamide is combined with Amantadine.

Mydriacyl Toxicity & Overdose Risk

The lowest toxic dose of tropicamide found in rats was 865mg/kg when taken orally, 1210mg/kg when taken intraperitoneally, and 872mg/kg when taken subcutaneously. While there is limited information about tropicamide overdose, some adverse effects such as rapid heart rate, changes to the nervous system, muscle stiffness, or reactions such as psychosis and vasomotor or cardio-respiratory collapse have been reported in children.

Mydriacyl Novel Uses: Which Conditions Have a Clinical Trial Featuring Mydriacyl?

A single investigation is being conducted to assess the potency of Mydriacyl in achieving partial cycloplegia, Ocular Anesthesia and Pupillary dilation for treatment of various disorders.

Condition

Clinical Trials

Trial Phases

Cycloplegia

0 Actively Recruiting

Ocular Anesthesia

0 Actively Recruiting

Pupil

0 Actively Recruiting

induction of Cycloplegia

0 Actively Recruiting

Epilepsies, Partial

16 Actively Recruiting

Phase 2, Early Phase 1, Phase 1, Not Applicable, Phase 3, Phase 4

diagnostic procedures

0 Actively Recruiting

Cataract Surgery

3 Actively Recruiting

Not Applicable, Phase 4

Induced Hyperthermia

0 Actively Recruiting

induction of partial cycloplegia

0 Actively Recruiting

Mydriacyl Reviews: What are patients saying about Mydriacyl?

3.7

Patient Review

4/19/2019

Mydriacyl for Dilated Pupils Before or After Surgery

I experienced some sharp pains in my head after taking this medication. Has anyone else had a similar experience?

1

Patient Review

12/8/2008

Mydriacyl for Dilated Pupils Before or After Surgery

Patient Q&A Section about mydriacyl

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does Mydriacyl take to work?

"Mydriacyl is typically used 15 to 20 minutes before an eye examination. One or two drops is the standard dose. Some people may feel a slight burning sensation in their eye(s) after using Mydriacyl."

Answered by AI

What is the generic name for Mydriacyl?

"TROPICamide is used for dilating the eye for examination and treating crossed eyes.

The generic name for TROPICamide is tropicamide. It is used for dilating the eye for examination and treating crossed eyes."

Answered by AI

Is Mydriacyl same as tropicamide?

"Tropicamide is a medication that dilates the pupil and prevents the muscle needed to focus from working, so that a person's eyes can be checked."

Answered by AI

What is Mydriacyl eye drops used for?

"This medication is used to widen the pupil of the eye in preparation for certain eye examinations. It belongs to a class of drugs known as cholinergics."

Answered by AI

Clinical Trials for Mydriacyl

Image of University of California, San Francisco in San Francisco, United States.

Vision Centers for Eye Care

Any Age
All Sexes
San Francisco, CA

The goal of this clinical trial is to evaluate the effect of vision centers on access to eye care and eye health outcomes in South Asia. The main questions it aims to answer are: 1. Do vision centers increase visits to eyecare centers? 2. Do vision centers increase spectacle ownership and wearing? 3. Do vision centers improve visual acuity of the population? Researchers will compare outcomes in communities randomized to have a vision center is established with communities randomized to delay establishment of a vision center. Outcomes will be assessed through population-based surveys at baseline and after two years as well as through hospital records collected throughout the study period.

Waitlist Available
Has No Placebo

University of California, San Francisco

Kieran O'Brien, PhD, MPH

Have you considered Mydriacyl clinical trials?

We made a collection of clinical trials featuring Mydriacyl, we think they might fit your search criteria.
Go to Trials

Have you considered Mydriacyl clinical trials?

We made a collection of clinical trials featuring Mydriacyl, we think they might fit your search criteria.
Go to Trials

Have you considered Mydriacyl clinical trials?

We made a collection of clinical trials featuring Mydriacyl, we think they might fit your search criteria.
Go to Trials